| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.12 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |